Follow
Andrew Hamann
Andrew Hamann
Research Assistant Professor, University of Nebraska-Lincoln
Verified email at unl.edu - Homepage
Title
Cited by
Cited by
Year
Nucleic acid delivery to mesenchymal stem cells: a review of nonviral methods and applications
A Hamann, A Nguyen, AK Pannier
Journal of biological engineering 13, 1-16, 2019
1142019
Mechanisms of unprimed and dexamethasone‐primed nonviral gene delivery to human mesenchymal stem cells
A Hamann, K Broad, A Nguyen, AK Pannier
Biotechnology and bioengineering 116 (2), 427-443, 2019
192019
Comparison of promoter, DNA vector, and cationic carrier for efficient transfection of hMSCs from multiple donors and tissue sources
T Kozisek, A Hamann, L Samuelson, M Fudolig, AK Pannier
Molecular Therapy-Nucleic Acids 26, 81-93, 2021
102021
Glucocorticoid priming of nonviral gene delivery to hMSCs increases transfection by reducing induced stresses
A Hamann, T Kozisek, K Broad, AK Pannier
Molecular Therapy-Methods & Clinical Development 18, 713-722, 2020
102020
Screening a chemically defined extracellular matrix mimetic substrate library to identify substrates that enhance substrate-mediated transfection
A Hamann, AK Thomas, T Kozisek, E Farris, S Lück, Y Zhang, AK Pannier
Experimental Biology and Medicine 245 (7), 606-619, 2020
92020
High-throughput screening of clinically approved drugs that prime nonviral gene delivery to human Mesenchymal stem cells
T Kozisek, A Hamann, A Nguyen, M Miller, S Plautz, AK Pannier
Journal of biological engineering 14, 1-13, 2020
72020
Innovative nonviral gene delivery strategies for engineering human mesenchymal stem cell phenotypes toward clinical applications
A Hamann, AK Pannier
Current opinion in biotechnology 78, 102819, 2022
42022
Systematic comparison of nonviral gene delivery strategies for efficient co-expression of two transgenes in human mesenchymal stem cells
T Kozisek, L Samuelson, A Hamann, AK Pannier
Journal of Biological Engineering 17 (1), 76, 2023
2023
Optimizing Nonviral CRISPR Epigenome Editing in Human Mesenchymal Stem Cells
A Hamann, K Broad, AK Pannier
MOLECULAR THERAPY 30 (4), 101-101, 2022
2022
Engineering Cells to Produce miRNA-Loaded Exosomes for Potential Biotherapeutics
J Weerakkody, K Broad, AK Pannier, A Hamann
MOLECULAR THERAPY 30 (4), 217-217, 2022
2022
Nonviral Gene Delivery of CRISPR Epigenome Editing System to Human Mesenchymal Stem Cells
A Hamann, K Broad, T Kozisek, AK Pannier
MOLECULAR THERAPY 29 (4), 202-203, 2021
2021
Identifying Molecular Mechanisms of Compounds That Prime Nonviral Gene Delivery to Human Mesenchymal Stem Cells
T Kozisek, A Hamann, AK Pannier
MOLECULAR THERAPY 29 (4), 211-212, 2021
2021
A Transgenic System for Active Loading of miRNAs into Exosomes Using Aptamers
A Hamann, K Broad, AK Pannier
MOLECULAR THERAPY 29 (4), 224-225, 2021
2021
Screening DNA Vectors for Enhanced Nonviral Gene Delivery to Human Mesenchymal Stem Cells
T Kozisek, A Hamann, L Samuelson, AK Pannier
MOLECULAR THERAPY 28 (4), 116-117, 2020
2020
A System for Active Loading of miRNAs into Exosomes
A Hamann, K Broad, AK Pannier
MOLECULAR THERAPY 28 (4), 299-300, 2020
2020
Original Research Highlight article
A Hamann, AK Thomas, T Kozisek, E Farris, S Luck, Y Zhang, AK Pannier
Experimental Biology and Medicine 245, 606-619, 2020
2020
Advancing Gene Delivery to Human Mesenchymal Stem Cells for Potential Therapeutic Applications
A Hamann
The University of Nebraska-Lincoln, 2020
2020
Chemical and Physical Priming of Human Mesenchymal Stem Cells to Alter Nonviral Gene Delivery Outcomes
T Kozisek, A Hamann, A Mantz, M Schubert, E Schubert, AK Pannier
2017
Enhancing Non-Viral Gene Delivery to Human Mesenchymal Stem Cells Using Glucocorticoid Priming
A Hamann
2017
The system can't perform the operation now. Try again later.
Articles 1–19